Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants (vol 24, pg 339, 2020)

被引:0
|
作者
Pestinger, Valerie [1 ]
Smith, Matthew [2 ]
Sillo, Toju [1 ]
Findlay, John M. [3 ]
Laes, Jean-Francois [4 ]
Martin, Gerald [5 ]
Middleton, Gary [6 ]
Taniere, Phillipe [2 ]
Beggs, Andrew D. [1 ,2 ]
机构
[1] Univ Birmingham, Surg Res Lab, Inst Canc & Genom Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England
[2] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England
[3] Northern Devon Healthcare NHS Trust, Barnstaple, England
[4] OncoDNA, Gosselies, Belgium
[5] PierianDx, St Louis, MO USA
[6] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1007/s40291-020-00479-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This article was originally published under a [CC BY NC 4.0] license.
引用
收藏
页码:505 / 505
页数:1
相关论文
共 4 条
  • [1] Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
    Valerie Pestinger
    Matthew Smith
    Toju Sillo
    John M. Findlay
    Jean-Francois Laes
    Gerald Martin
    Gary Middleton
    Phillipe Taniere
    Andrew D. Beggs
    Molecular Diagnosis & Therapy, 2020, 24 : 339 - 349
  • [2] Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
    Pestinger, Valerie
    Smith, Matthew
    Sillo, Toju
    Findlay, John M.
    Laes, Jean-Francois
    Martin, Gerald
    Middleton, Gary
    Taniere, Phillipe
    Beggs, Andrew D.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (03) : 339 - 349
  • [3] Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
    Valerie Pestinger
    Matthew Smith
    Toju Sillo
    John M. Findlay
    Jean‑Francois Laes
    Gerald Martin
    Gary Middleton
    Phillipe Taniere
    Andrew D. Beggs
    Molecular Diagnosis & Therapy, 2020, 24 : 505 - 505
  • [4] Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial (vol 137, pg 250, 2020)
    Stahler, Arndt
    Stintzing, Sebastian
    von Einem, Jobst C.
    Westphalen , Christoph B.
    Heinrich, Kathrin
    Kraemer, Nicole
    Michl, Marlies
    Modest, Dominik P.
    von Weikersthal, Ludwig Fischer
    Decker, Thomas
    Kiani, Alexander
    Heintges, Tobias
    Kahl, Christoph
    Kullmann, Frank
    Scheithauer, Werner
    Moehler, Markus
    Kaiser, Florian
    Kirchner, Thomas
    Jung, Andreas
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2022, 169 : 223 - 225